Mobile

Study investigating a standard treatment in kidney transplant patients versus a treatment with Certican® in combination with Cyclosporin A or Tacrolimus

Update Il y a 4 ans
Reference: EUCTR2011-005238-21

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To demonstrate non-inferiority in renal function assessed by glomerular filtration rate (Nankivell formula) in at least one of the Certican® treatment regimens compared to the standard group at month 12 post-transplantation in renal transplant patients.

Inclusion criteria

  • Kidney Transplantation

Links